M56-S2 iodide is a SARS-CoV-2 Mpro inhibitor (IC50 = 4.0 μM) with potential antiviral applications, particularly against SARS-CoV-2; it exhibits good drug-like properties, including favorable oral bioavailability and low toxicity in ADMET predictions.